Have you been diagnosed with an advanced cancer that has not responded to or has stopped responding to treatment? Have you had genetic testing done on your cancer? If so you may be able to take park in a research study to observe how certain cancer drugs target tumor DNA. Travel reimbursement provided.
Have you been diagnosed with cervical cancer? If so, you may be able to take part in a research study that aims to identify a new non-invasive biomarker (blood test) to 1) detect cervical cancer during screenings and 2) track response to treatment, detect early recurrence and guide personalized treatment decisions. In this study we will measure levels of Circulating Tumor Human Papilloma Virus DNA (ctHPVDNA) levels in the blood and urine of women with newly diagnosed cervical cancer prior to receiving any treatment, and then compare this to the levels in samples collected after treatment (surgery of chemoradiation).
People with Barrett's esophagus are at higher than average risk of developing esophageal cancer. Obeticholic Acid (OCA) is a medication similar to bile acids (a fluid made and released by the liver). OCA binds to a group of cells in the intestine that is believed to have a positive effect on preventing cancer development. The purpose of this study is to compare the safety and effects of OCA with that of a placebo on the risk of developing esophageal cancer in people with Barrett's esophagus.
Have you been diagnosed with Pancreatic Cancer. If so, you may be able to take part in a research study looking at the safety of giving a drug called CA-4948 Added to Standard Chemotherapy to Treat Metastatic or Unresectable Pancreatic Cancer
Have you been newly diagnosed with or suspected of having either acute myelogenous leukemia or high risk myeloid neoplasm? Are you looking for other treatment options? In this study, depending on the specific type of leukemia you have, our study team will determine the different treatment options that we can provide to you.
This is a Phase 2 clinical trial to test the response of the drug combination of ZEN003694 and Talazoparib. In this study, we want to learn whether this combination works to slow the growth of cancer.
Do you have head and neck cancer or soft tissue sarcoma? Are you planning to have surgery to remove your tumor? You may be able to participate in a research study to determine which therapies may be best for future patients. Compensation provided.
To explore possible reasons for low registration of students to the LCTLs at UNC
In this study, we want to learn how we can increase awareness and availability of specialty pain care services for Black men. We will do this by asking questions about physical health, access to health care, decision-making, and factors that impact someone's health.
In this study, we want to learn more about the impact of micro-influencers on young adults between ages 18 and 25.